Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: A Study to Test Whether Survodutide Improves How the Body Uses Energy and Breaks Down Fat in People With Obesity [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update examining whether Survodutide improves energy use and fat metabolism in people with obesity. The study is active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Survodutide (BI456906)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Obesity | Phase 1 | Status: ACTIVE_NOT_RECRUITING